Clinical Trials on 转移性乳腺癌 in Australia
总计570个结果
-
Elisabethinen HospitalMedical University Innsbruck招聘中
-
EpiAxis TherapeuticsThe Canberra Hospital; Southern Medical Day Care Centre; Liverpool Cancer Therapy Centre完全的
-
AO Innovation Translation CenterAO Foundation, AO Spine招聘中
-
Lawson Health Research InstituteVU University of Amsterdam; London Regional Cancer Program, Canada主动,不招人
-
Genentech, Inc.主动,不招人晚期/转移性肿瘤西班牙, 美国, 大韩民国, 澳大利亚, 法国, 日本, 加拿大
-
David PalmaLondon Health Sciences Centre; Amsterdam University Medical Centre, VUmc Site; British Columbia... 和其他合作者主动,不招人
-
TakedaTakeda Development Center Americas, Inc.招聘中
-
British Columbia Cancer AgencyThe Alfred; London Regional Cancer Program, Canada; Tom Baker Cancer Centre; Cancer Trials Ireland; Beatson West of Scotland Cancer Centre 和其他合作者招聘中
-
Ludwig Institute for Cancer ResearchDaiichi Sankyo Co., Ltd.; Austin Health完全的
-
Antengene Therapeutics LimitedMerck Sharp & Dohme LLC招聘中
-
German Cancer Research CenterUniversity Hospital Freiburg; ABX CRO; Friedrich-Alexander-Universität Erlangen-Nürnberg完全的
-
SanofiMirati Therapeutics Inc.; Revolution Medicines, Inc.终止
-
PharmAbcineMerck Sharp & Dohme LLC; Novotech (Australia) Pty Limited尚未招聘
-
Daiichi SankyoAstraZeneca招聘中
-
Provectus Biopharmaceuticals, Inc.主动,不招人
-
Spago Nanomedical AB招聘中
-
Navire Pharma Inc., a BridgeBio companyAmgen招聘中非小细胞肺癌 | 转移性实体瘤 | 实体瘤,成人 | 转移性非小细胞肺癌西班牙, 澳大利亚, 法国, 丹麦, 希腊, 意大利, 荷兰
-
ETOP IBCSG Partners FoundationBreast International Group完全的
-
Melanoma and Skin Cancer Trials LimitedUniversity of Oxford; Trans Tasman Radiation Oncology Group主动,不招人
-
Medical University InnsbruckMarcel Seiz-Rosenhagen MD, PD; Meinhard Nevinny-Stickel MD, Prof.; Christian F Freyschlag MD; Günther... 和其他合作者未知
-
Telix Pharmaceuticals (Innovations) Pty Limited完全的
-
Peter MacCallum Cancer Centre, AustraliaNovartis Pharmaceuticals完全的
-
Ludwig Institute for Cancer ResearchBristol-Myers Squibb终止
-
AmgenRoche-Genentech完全的转移性结直肠癌 | 转移性三阴性乳腺癌美国, 比利时, 西班牙, 澳大利亚, 瑞士, 德国
-
Amunix, a Sanofi CompanyMerck Sharp & Dohme LLC招聘中局部晚期或转移性 HER2 表达癌症澳大利亚, 西班牙, 法国, 葡萄牙